Vicore Pharma Holding AB (publ)
STO: VICO.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ahmed S. Mousa
- Employees
- 33
- Headquarters
- Stockholm, Sweden
- IPO year
- 2015
- Market cap
- SEK 2.6B
- Website
- https://www.vicorepharma.com
Loading VICO…
Loading profile data…Frequently asked questions about VICO
What does Vicore Pharma Holding AB (publ) (VICO.ST) do?
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), sy...
Where does VICO.ST trade?
Vicore Pharma Holding AB (publ) (VICO.ST) trades on the Stockholm Stock Exchange.
What sector is VICO.ST in?
Vicore Pharma Holding AB (publ) (VICO.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vicore Pharma Holding AB (publ)?
Ahmed S. Mousa is the chief executive officer of Vicore Pharma Holding AB (publ) (VICO.ST).
Where is Vicore Pharma Holding AB (publ) headquartered?
Vicore Pharma Holding AB (publ) is headquartered in Sweden.
Does VICO.ST pay a dividend?
Vicore Pharma Holding AB (publ) (VICO.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VICO.ST go public?
Vicore Pharma Holding AB (publ) (VICO.ST) completed its initial public offering in 2015.